121 related articles for article (PubMed ID: 10715870)
21. Evidence-based medicine in practice.
Hampton JR
Practitioner; 1999 Oct; 243(1603):693. PubMed ID: 10715867
[No Abstract] [Full Text] [Related]
22. Cardiovascular and hypertension targets in the health plan for Catalonia (Spain).
Pardell H; Tresserras R; Taberner JL; Via JM; Salleras L
J Hum Hypertens; 1993 Dec; 7(6):543-5. PubMed ID: 8114043
[No Abstract] [Full Text] [Related]
23. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
[TBL] [Abstract][Full Text] [Related]
24. [Consensus for the control of cholesterolemia and hypertension and the prevention of cardiovascular diseases in Spain].
Balaguer Vintro I
Rev Sanid Hig Publica (Madr); 1990; 64(7-8):343-6. PubMed ID: 2131616
[No Abstract] [Full Text] [Related]
25. [European practice guidelines on prevention of cardiovascular diseases: executive summary].
Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; ;
G Ital Cardiol (Rome); 2008 Jan; 9(1):11-59. PubMed ID: 18383763
[No Abstract] [Full Text] [Related]
26. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
27. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
28. Foreword: state of the science: physiological evaluation of cardiovascular status.
Frazier SK
J Cardiovasc Nurs; 2008; 23(2):103-4. PubMed ID: 18382251
[No Abstract] [Full Text] [Related]
29. [Prevention in cardiovascular pathology].
Chamontin B; Amar J
Therapie; 2001; 56(2):119-24. PubMed ID: 11471362
[TBL] [Abstract][Full Text] [Related]
30. [Presentation: European practice guidelines for the prevention of cardiovascular diseases in clinical practice].
Di Pasquale G
G Ital Cardiol (Rome); 2008 Jan; 9(1):9-10. PubMed ID: 18383762
[No Abstract] [Full Text] [Related]
31. An evidence based clinical aid for cardiovascular disease--what do GPs think?
Mcavoy BR; Fulcher GR; Amerena JV; Conner GW; Beltrame JF; Hankey GJ; Keech AC; Lloyd BL; Neale ML; Pollock CA; Sudhir K; Waltham RD; West MJ;
Aust Fam Physician; 2005 Apr; 34(4):297-8. PubMed ID: 15861759
[No Abstract] [Full Text] [Related]
32. Assessment and management of cardiovascular risk in men.
McBride PE; Ryan G
Prim Care; 2006 Mar; 33(1):75-91, viii-ix. PubMed ID: 16516681
[No Abstract] [Full Text] [Related]
33. No evidence for marked ethnic differences in accuracy of self-reported diabetes, hypertension, and hypercholesterolemia.
El Fakiri F; Bruijnzeels MA; Hoes AW
J Clin Epidemiol; 2007 Dec; 60(12):1271-9. PubMed ID: 17998082
[TBL] [Abstract][Full Text] [Related]
34. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
35. [Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty].
Beermann B
Lakartidningen; 2006 Nov 22-28; 103(47):3731-2. PubMed ID: 17212324
[No Abstract] [Full Text] [Related]
36. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective.
Valdez R; Greenlund KJ; Khoury MJ; Yoon PW
Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009
[TBL] [Abstract][Full Text] [Related]
37. [Prevention of cardiovascular diseases:a medical-economic approach].
Therapie; 2001; 56(2):125-30. PubMed ID: 11484713
[No Abstract] [Full Text] [Related]
38. New guidelines suggest childhood training for cardiovascular health.
Levenson D
Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):7-9. PubMed ID: 12518773
[No Abstract] [Full Text] [Related]
39. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
[TBL] [Abstract][Full Text] [Related]
40. [Amlodipine better than atenolol in hypertension. More efficient prevention of the mortality and cardiovascular events according to the ASCOT trial].
Nilsson PM; Håkansson J
Lakartidningen; 2005 Oct 10-16; 102(41):2922-3. PubMed ID: 16294509
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
